UroToday - Prostate Cancer

Home

Prostate Cancer

UroToday's Prostate Cancer section is a repository of the clinical publications, clinical trials and investigative science pertaining to the diagnosis and treatment of prostate cancer. Also available are conference coverage for all timely prostate cancer science, streaming media presentations, audio podcasts and downloadable slides from UroToday's slide library.

Online Urology & Urologic Oncology Journal
Please read about the UroToday International Journal; We welcome submissions year round and are committed to providing fast-tracked, peer reviewed publication.
Kind Regards,
Christopher P. Evans MD,
Associate Section Editor of Oncology/Prostate Cancer,
UroToday International Journal

Display

results per page

Results 31 - 60 of 6226

<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Beyond the Abstract - Male stress urinary incontinence: The place of alternatives to an artificial urinary sphincter, by Philippe Grise, MD
Tuesday, 16 March 2010
BERKELEY, CA (UroToday.com) - The number of patients suffering from postprostatectomy incontinence is increasing despite improvements in surgical techniques.
Login to read more...

Prospective comparison of PSA kinetics following two different prostate cancer brachytherapy planning methods: Preoperative and real-time intraoperative dosimetry planning - Abstract
Tuesday, 16 March 2010
Department of Urology, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
read more

111-In-capromab pendetide imaging using hybrid-gamma camera-computer tomography technology is not reliable in detecting seminal vesicle invasion in patients with prostate cancer - Abstract
Tuesday, 16 March 2010
Duke Prostate Center and Division of Urologic Surgery, Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA.
read more

Pelvic lymphadenectomy and radical prostatectomy : Recommendations of the German S3 guideline - Abstract
Tuesday, 16 March 2010
Klinik und Poliklinik für Urologie, Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden, Fetscherstrasse 74, 01307 Dresden.
read more

Pooled analysis of phosphatidylinositol 3-kinase pathway variants and risk of prostate cancer - Abstract
Tuesday, 16 March 2010
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA.
read more

Value of magnetic resonance spectroscopy imaging and dynamic contrast-enhanced imaging for detecting prostate cancer foci in men with prior negative biopsy - Abstract
Tuesday, 16 March 2010
Departments of Urology and Radiology, University Sapienza, and Department of Urology, University of Rome, Rome, Italy.
read more

Quality of end-of-life care in low-income, uninsured men dying of prostate cancer - Abstract
Tuesday, 16 March 2010
Department of Urology, University of California at Los Angeles, Los Angeles, California.
read more

Evaluation of continuous low dose rate versus acute single high dose rate radiation combined with oncolytic viral therapy for prostate cancer - Abstract
Tuesday, 16 March 2010
James Brady Urological Institute, Johns Hopkins University School of Medicine, 600 N. Wolfe Street, Marburg Room 205A, Baltimore, MD 21287-2101, USA.
read more

Beyond the Abstract - Magnetic resonance spectroscopic imaging ((1)H-MRSI) and dynamic contrast-enhanced magnetic resonance (DCE-MRI): Pattern changes from inflammation to prostate cancer, by Alessandro Sciarra, MD, et al.
Monday, 15 March 2010
BERKELEY, CA (UroToday.com) - Recent studies have shown a highly suggestive correlation between prostatitis, chronic inflammation, and the diagnosis of PCa.
Login to read more...

Why do men opt out of prostate-cancer screening? Attitudes and perception among participants and non-participants of a screening trial - Abstract
Monday, 15 March 2010
Department of Urology, Helsinki University Central Hospital, Helsinki, Finland.
read more

A paradigm shift : Defensive strategies for the treatment of localized prostate cancer in the new S3 guideline - Abstract
Monday, 15 March 2010
Stiftung Männergesundheit, Reinhardtstrasse 2, 10117 Berlin.
read more

Prostate-specific antigen (PSA) isoform p2PSA in combination with total PSA and free PSA improves diagnostic accuracy in prostate cancer detection - Abstract
Monday, 15 March 2010
Department of Urology, Erasmus MC, Rotterdam, The Netherlands.
read more

Nerve-sparing robotic prostatectomy in preoperatively high-risk patients is safe and efficacious - Abstract
Monday, 15 March 2010
Department of Urology, Division of Robotics and Minimally Invasive Surgery, The Mount Sinai Medical Center, New York, NY 10022, USA.
read more

Androgen depletion up-regulates cadherin-11 expression in prostate cancer - Abstract
Monday, 15 March 2010
Department of Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
read more

The influence of hepatic function on prostate cancer outcomes after radical prostatectomy - Abstract
Monday, 15 March 2010
Division of Urologic Surgery and the Duke Prostate Center, Department of Surgery, Duke University Medical Center and Urology Section, Veterans Affairs Medical Center, Durham, NC, USA.
read more

Effect of the correction for non-compliance and contamination on the estimated reduction of metastatic prostate cancer within a randomized screening trial (ERSPC section Rotterdam) - Abstract
Monday, 15 March 2010
Department of Urology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands.
read more

American Cancer Society guideline for the early detection of prostate cancer: Update 2010 - Abstract
Monday, 15 March 2010
University of Virginia School of Medicine, Charlottesville, VA.
read more

American Cancer Society Guideline for the Early Detection of Prostate Cancer: Update 2010
Monday, 15 March 2010
read more

Editorial - Prostate-specific antigen screening in the United States vs in the European Randomized Study of Screening for Prostate Cancer-Rotterdam
Friday, 12 March 2010
BERKELEY, CA (UroToday.com) - In the Journal of the National Cancer Institute, Dr. Elizabeth Wever and investigators from Rotterdam report that PSA screening in detecting prostate cancer (CaP) was lower in the United States than in the European Randomized Study of Screening for Prostate Cancer-Rotterdam (ERSPC-Rotterdam).
Login to read more...

Comparative effectiveness of prostate cancer surgical treatments: A population based analysis of postoperative outcomes - Abstract
Friday, 12 March 2010
Urology Service, Department of Surgery, Sidney Kimmel Center for Prostate and Urologic Cancers, and Health Outcomes Research Group, Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York.
read more

Relationship between tumor volume and PSA recurrence after radical prostatectomy - Abstract
Friday, 12 March 2010
The Department of Urology, Hirosaki University Graduate School of Medicine, Japan.
read more

Imaging modalities for primary diagnosis and staging of prostate cancer - Abstract
Friday, 12 March 2010
Institut für klinische Radiologie, LMU München, Klinikum der Universität München, Ziemssenstrasse 1, 80336 München.
read more

Changes in specific domains of sexual function and sexual bother after radical prostatectomy - Abstract
Friday, 12 March 2010
Yale School of Medicine, New Haven, CT, USA.
read more

Update on radiation-based therapies for prostate cancer - Abstract
Friday, 12 March 2010
Department of Radiation Oncology, University of Maryland School of Medicine, University of Maryland Medical Center, Baltimore, Maryland, USA.
read more

Psychosocial issues related to sexual functioning among African-American prostate cancer survivors and their spouses - Abstract
Friday, 12 March 2010
Moffitt Cancer Center and Research Institute, Department of Health Outcomes and Behavior, Magnolia Drive, Tampa, FL, USA.
read more

Validation of automatic target volume definition as demonstrated for (11)C-choline PET/CT of human prostate cancer using multi-modality fusion techniques - Abstract
Friday, 12 March 2010
Department of Biomedical Engineering, Gachon University of Medicine and Science, Incheon 406-799, South Korea.
read more

Intra-fraction prostate displacement in radiotherapy estimated from pre- and post-treatment imaging of patients with implanted fiducial markers - Abstract
Friday, 12 March 2010
Physical Sciences, Peter MacCallum Cancer Centre, Melbourne, Australia.
read more

Rising PSA level and negative prostate biopsy : Can prostate elastography help? - Abstract
Thursday, 11 March 2010
Urologische Klinik, Ruhr-Universität Bochum, Marienhospital Herne, Widumer Strasse 8, 44627, Herne, Deutschland.
read more

Current status of immunological therapies for prostate cancer - Abstract
Thursday, 11 March 2010
Department of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland, USA.
read more

Methodology and process of developing the S3 guideline for prostate cancer - Abstract
Thursday, 11 March 2010
Bereich evidenzbasierte Medizin und Leitlinien, Arztliches Zentrum für Qualität in der Medizin, Wegelystrasse 3, 10623 Berlin.
read more

Focus on Prostate Cancer

Focus on Prostate Cancer condenses a selection of compelling and relevant science - on topic and chosen by the UroToday.com editorial staff.




Prostate Cancer - Prognostic Nomograms - by Ricardo Sanchez-Ortiz, MD EAU Position Statement on Screening for Prostate Cancer - News Release Anxiety and distress during active surveillance for early prostate cancer - by Roderick C.N. van den Bergh, MD, et al. Degarelix: A new approach for the treatment of prostate cancer - by Bo-Eric Persson, MD A 64-year-old man with low-risk prostate cancer: Review of prostate cancer treatment - by Sandip M. Prasad, MD and Martin G. Sanda, MD - Editor's Pick Apocrine Sweat Gland Obstruction by Antiperspirants Allowing Transdermal Absorption of Cutaneous Generated Hormones and Pheromones as a Link to the Observed Incidence Rates of Breast and Prostate Cancer in the 20th Century - by Kris G. McGrath, MD A Novel Communication Role for CYP17A1 in the Progression of Castration-Resistant Prostate Cancer - by Emma Tomlinson Guns, PhD Phase I/II Trial of Docetaxel and Concurrent Radiation Therapy in Localized High Risk Prostate Cancer (AGUSG 03-10) - by Michael Perrotti, MD, et al. A 1-Year, Open Label, Randomized Phase II Dose Finding Study of Degarelix for the Treatment of Prostate Cancer in North America - by Marc Gittelman, MD - Editor's Pick Management of the Side Effects of Androgen Deprivation Therapy in Men with Prostate Cancer - by Thomas W Flaig, MD Sexually Transmissible Infections and Prostate Cancer Risk - by Wen-Yi Huang, PhD, MSPH, et al. Serum Calcium and Incident and Fatal Prostate Cancer in the National Health and Nutrition Examination Survey - by Gary G. Schwartz, PhD, MPH - Editor's Pick Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005 - by Christopher P. Evans, MD, FACS Periurethral suspension stitch during robot-assisted laparoscopic radical prostatectomy: Description of the technique and continence outcomes - by Christopher P. Evans, MD, FACS Duplicate presentations on prostate cancer at American Urological Association and European Association of Urology annual meetings - by Christopher P. Evans, MD, FACS High-Dose-Rate Brachytherapy for Localized Prostate Adenocarcinoma Post Abdominoperineal Resection of the Rectum and Pelvic Irradiation: Technique and Experience - by Christopher P. Evans, MD, FACS Impact of Surgeon and Hospital Volume on Outcomes of Radical Prostatectomy - by Christopher P. Evans, MD, FACS PCPT: Evidence That Finasteride Reduces Risk of Most Frequently Detected Intermediate- And High-Grade (Gleason Score 6 and 7) Cancer - by Christopher P. Evans, MD, FACS A Broader Role for 5ARIs in Prostate Disease? Existing Evidence and Emerging Benefits - by Christopher P. Evans, MD, FACS Patient Anxiety About Prostate Cancer Independently Predicts Early Initiation of Androgen Deprivation Therapy for Biochemical Cancer Recurrence in Older Men: A Prospective Cohort Study - by Christopher P. Evans, MD, FACS - Editor's Pick Predicting Prostate Cancer Risk Through Incorporation of Prostate Cancer Gene 3 - by Christopher P. Evans, MD, FACS HIV and Prostate Cancer: A Systematic Review of the Literature - by Christopher P. Evans, MD, FACS - Editor's Pick Obesity-Related Plasma Hemodilution and PSA Concentration among Men with Prostate Cancer - by Christopher P. Evans, MD, FACS - Editor's Pick Androgen Deprivation Therapy for Localized Prostate Cancer and the Risk of Cardiovascular Mortality - by Christopher P. Evans, MD, FACS Editor's Pick Patient Response to Total Intravenous Sedation (TIVS) for Outpatient Ultrasound-Guided Prostate Biopsy - by Ahmed Al-Sameraaii, MD, et al. A Four-Gene Expression Signature for Prostate Cancer Cells Consisting of UAP1, PDLIM5, IMPDH2, and HSPD1 - by Herbert A. Fritsche, PhD, et al. Peripheral Zone Sonographic Changes of the Prostate - by El-Housseiny Ismail Ibrahiem (El- Zalouey), MD, et al. Successful Early Prostate Cancer Screening by Three-Dimensional Color Doppler Imaging-Transrectal Ultrasound: A Prospective Study - by Walter Merkle, MD Mechanism of Neuroendocrine Differentiation in Prostate Cancer: BMP6-Macrophage-IL6 Loop via Obligatory Involvement of Both Smad-Dependent and -Independent Pathway - by Isaac Yi Kim, MD, et al. Secondary Therapy In Localized Prostate Cancer: Results From The Prostate Cancer Outcomes Study - by David F. Penson, MD, et al. Prostate Cancer Diagnosis in High Risk Patients The Finasteride Challenge Trial - by Bernd J Schmitz-Dräger, MD, et al. Key targets of hormonal treatment of prostate cancer. Part 2: The androgen receptor and 5α-reductase Robotic-assisted radical prostatectomy: A review of current outcomes Locally advanced prostate cancer: the role of surgical management Key targets of hormonal treatment of prostate cancer. Part 1: The androgen receptor and steroidogenic pathways Prostate Cancer: A Serious Disease Suitable for Prevention Prostate-Specific Antigen Kinetics in Localized and Advanced Prostate Cancer
SIU Satellite Symposium 2007 Advanced Prostate Cancer: Current Status, Controversies, and Future Directions By Fred Saad, MD, FRCS Bone Metastases Module By Edward Chow MBBS, PhD, FRCPC Accompanying Case Studies A 64 year old retired pharmacist presents to his primary care physician with complaints of urinary urgency and frequency of 6 months duration and of increasingly severe low back and right hip pain of 3 months duration. A 73 year old retired commericial fisherman was diagnosed 3 years ago with a Stage IV [Gleason 3 + 3(6)] prostate cancer with bone being the only site of metastases. A 55 year old woman presents to her primary care physician with occasional gross painless hematuria for 4 months. A 59 year old male had a diagnosis of renal cell carcinoma of the left kidney made 2 years ago after presenting with flank pain and hematuria.
9th International Prostate Forum - View Session Highlights Evaluation of the prostate cancer prevention trial risk calculator in a high-risk screening population - Session Highlight by Thomas J. Guzzo, MD, MPH from the AUA Mid-Atlantic Section 67th Annual Meeting What to do when the pathologist reports "positive margins" - Multimedia Lecture by William J. Catalona, MD from the AUA NY Section 107th Annual Meeting Open prostatectomy is best - Multimedia Lecture by William J. Catalona, MD from the AUA NY Section 107th Annual Meeting One year result of the retrourethral transobturator sling for the minimal-invasive treatment of male stress incontinence after radical prostatectomy - Slide Presentation by Christian G. Stief, MD at the Urological Research Society (URS) 25th Annual Meeting Prostate cancer detection using a novel computerized three-dimensional prostate biopsy template (Targetscan™): Results of a multicenter prospective data registry - Slide Presentation - Slide Presentation by Samir S. Taneja, MD at the Urological Research Society (URS) 25th Annual Meeting VI Maratona Urológica do Rio de Janeiro - View Prostate Cancer Session Highlights VI Maratona Urológica do Rio de Janeiro - View Prostate Cancer Slide Presentations American Society of Clinical Oncology (ASCO) 2009 Annual Meeting - View Prostate Cancer Session Highlights American Urological Association (AUA) 2009 Annual Meeting - View Prostate Cancer Session Highlights Post Prostatectomy Incontinence Study - SUFU 2009 - Highlight of a Presentation by Victor W. Nitti, MD Open, Laparoscopic and Robotic Prostatectomy: Much Ado About Nothing? - WUF 2009 - Lecture Presented by Christopher P. Evans, MD, FACS Society of Urologic Oncology (SUO) 9th Annual Winter Meeting - View Prostate Cancer Session Highlights Options in Prostate Cancer Surgery: Perineal Prostatectomy in the Age of Minimally Invasive Surgery - Masters in Urology 2008 - Slide Presentation Options in Prostate Cancer Surgery: Perineal Prostatectomy in the Age of Minimally Invasive Surgery - Masters in Urology 2008 - Slide Presentation Advances in the Treatment of Hormone Refractory Prostate Cancer - Masters in Urology 2008 - Session Highlight The American Society for Therapeutic Radiology and Oncology - 50th Annual Meeting - ASTRO 2008 - Prostate Cancer Abstracts American Society of Clinical Oncology - 44th Annual Meeting - ASCO 2008 - Prostate Cancer Abstracts The American Urological Association 2008 Annual Meeting - AUA 2008 Prostate Cancer Session Highlights Engineering and Urology Society - 23rd Annual Meeting - EUS 2008 - Prostate Cancer Abstracts